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ABSTRACT 
 
Previous studies have shown CD34 family member Podocalyxin is required for epithelial lumen 
formation in vitro. We demonstrate that Endoglycan, a CD34 family member with homology to 
Podocalyxin, is produced prior to lumen formation in developing nephrons. Endoglycan localizes to 
Rab11-containing vesicles in nephron progenitors, and then relocalizes to the apical surface as 
progenitors epithelialize. Once an apical/luminal surface is formed, Endoglycan (and the actin-binding 
protein Ezrin) localize to large, intraluminal structures that may be vesicles/exosomes. We generated 
mice lacking Endoglycan and found mutants had timely initiation of lumen formation and continuous 
lumens, similar to controls. Mice with conditional deletion of both Endoglycan and Podocalyxin in 
developing nephrons also had normal tubular lumens. Despite this, Endoglycan/Podocalyxin is 
required for apical recruitment of the adaptor protein NHERF1, but not Ezrin, in podocyte precursors, 
a subset of the epithelia. In summary, while CD34 family members appear dispensable for lumen 
formation, our data identify Endoglycan as a novel pre-luminal marker and suggest lumen formation 
occurs via vesicular trafficking of apical cargo that includes Endoglycan.  
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INTRODUCTION 
 
Epithelial tubules are a component of many organs, including the kidney [1, 2]. A central 
feature of tubulogenesis is the segregation of spatially and functionally distinct plasma membrane 
surfaces, called apical-basal polarization, within each cell. The polarization of individual cells is 
coordinated with surrounding cells, forming a continuous apical surface at the site of the tubule 
lumen. 
Renal epithelial tubules are characterized by a single, central lumen at the apical surface of 
cells. Despite this commonality, renal tubules derive from two different embryonic sources, the 
ureteric bud epithelium and the metanephric mesenchyme, which form tubules by different cellular 
mechanisms [3]. It is the reciprocal interactions between these two tissues that allow for the 
generation of nephron tubules. Signals from the metanephric mesenchyme induce the branching of 
the ureteric bud epithelia, which buds from a pre-existing tubule. Conversely, the ureteric bud 
epithelia signals to the metanephric mesenchyme, inducing a subset of the mesenchyme containing 
nephron progenitor cells (the cap mesenchyme, CM) to undergo compaction and then a 
mesenchymal-to-epithelial transition (MET), forming a sphere of polarized epithelia with a central 
lumen (Fig 1A).  This polarized sphere, called a renal vesicle (RV), subsequently elongates to form a 
primordial tubule called the s-shaped body (SB). Each developing s-shaped body will fuse with the tip 
of an adjacent ureteric bud tubule, thus forming a continuous lumen. The s-shaped body 
subsequently undergoes extensive morphogenesis to form the epithelial tubules of nephrons, while 
the UB gives rise to the collecting duct system. 
The lumen of the UB arises as an extension of a pre-existing lumen, as it generally does when 
a tubule forms as a bud of a pre-existing tubule. In contrast, the lumen of the nascent nephron arises 
de novo during MET and polarization [4]. How the nephron lumen arises is not clear, and this is an 
outstanding question in the field. Much of our knowledge of the cellular and molecular mechanisms of 
nephron lumen formation has arisen from 3D culture of a well-established renal epithelial cell line, 
Madin Darby Canine Kidney (MDCK) cells. Indeed use of this culture model has allowed for 
dissection of many aspects of epithelial polarity and lumen formation [5].  
One protein that has a central role in MDCK epithelial polarity is Podocalyxin. Podocalyxin is a 
member of the CD34 family of sialomucins, which is comprised of CD34, Podocalyxin and 
Endoglycan (Podocalyxin-2). CD34 family members have been shown to be markers of tissue-
specific stem cells and play roles in several biological functions, including tubulogenesis, adhesion, 
cell morphology, and homing of hematopoietic stem cells [6]. Numerous in vitro studies have shown a 
central role for Podocalyxin in epithelial polarity. Podocalyxin interacts directly with the adaptor 
proteins NHERF1/2 and Ezrin, forming a ternary complex at the apical surface that is tethered to the 
actin cytoskeleton through Ezrin [7-10]. Polarized distribution of Podocalyxin/NHERF to the free 
surface of single MDCK cells attached to a culture dish is an early event in epithelial polarization, and 
Podocalyxin allows segregation of apical and basolateral domains in an epithelial monolayer [11]. In 
addition, Podocalyxin (and Ezrin) expression drives expansion of apical surfaces by increasing 
microvilli number and length [12-14]. Finally, Podocalyxin appears to function as an anti-adhesive, 
causing cell-cell repulsion via its negatively charged sialic acids [15].   
Depletion of Podocalyxin from 3D MDCK cultures leads to formation of multiple lumens with 
cytosolic redistribution of NHERF1 [10]. Podocalyxin-depleted cysts mislocalize several apically 
located proteins, such as Crb3, to sub-apical Rab11-positive vesicles. Interestingly, the phenotype is 
not one of absent or collapsed lumens, as might be expected from Podocalyxin’s numerous functions. 
Consistent with these findings, individual depletion of Ezrin or NHERF1, -2, or -3 in vitro also leads to 
multiple lumens [10]. Collectively, these results suggest a critical role for Podocalyxin/NHERF/Ezrin 
complexes in generating apical-basal polarity and a continuous apical surface.  
Despite its essential role in in vitro renal epithelia, Podocalyxin expression in the kidney is 
reported to be limited to hematopoietic progenitors, vascular endothelia, and podocytes [16, 17]. It 
localizes to the apical surface of developing and mature podocytes [18, 19], where it plays a critical 
role in the formation of foot processes and slit diaphragms [20]. Mice lacking Podocalyxin die in the 
neonatal period with anuric renal failure [20]. Podocalyxin function is also important in human 
podocytes: exome sequencing has identified a mutation in Podxl1 as a likely candidate for autosomal 
dominant focal segmental glomerulosclerosis [21]. 
 The lack of significant Podocalyxin in vivo during renal epithelial tubulogenesis and lumen 
formation led us to examine if other CD34 family members are expressed in developing and mature 
renal epithelia. Herein we find that Endoglycan localizes to intracellular vesicles within progenitors of 
nephron epithelia and at the apical/luminal surface coincident with lumen initiation. Although we find 
that Endoglycan is not required for lumen formation per se, our results support a model in which 
intracellular vesicles containing apical components traffic to a forming apical surface to generate a 
tubular lumen.  
 
MATERIALS AND METHODS 
 
Animals: 
We generated and tested mice from three validated clones of Podxl2tm1a(EUCOMM)Wtsi ES cells through 
use of the UTSW Transgenic core facility. Mice derived from clone EPD0647_7_C06 were used for 
this paper. The Podxl2tm1a allele is a targeted trap allele that functions as a gene-trap knockout. Mice 
carrying the Podxl2tm1a/tm1a allele were screened by PCR for correct targeting, and lack of Endoglycan 
(EG or Podocalyxin-like 2) was verified by immunofluorescence. We also generated mice with a 
conditional EG allele by mating Podxl2tm1a mice to mice carrying ubiquitous expression of FlpE 
recombinase (β-actin-FlpE mice) [22]. In this conditional allele of EG, exons 3 and 4 are flanked by 
loxP sites. Exons 3 and 4 are comprised of 869 base pairs that encode for amino acids 48 to 337 of 
Endoglycan. The excision of these two exons causes a frameshift mutation in subsequent exons, 
resulting in a stop codon after 114 base pairs. 
 Conditional Podxl2flox/flox (hereafter referred to as EGflox/flox) mice were mated with mice carrying 
conditional alleles of Podocalyxin (Podxl1flox/flox) [23] to generate EGflox/flox; Podxl1flox/flox mice. The 
doubly conditional mice were crossed to Six2-cre and Pax3-cre transgenic mice [24, 25] to obtain 
EGflox/flox; Podxl1flox/flox; Six2-eGFP-cre and EGflox/flox; Podxl1flox/flox; Pax3-cre mutant embryos. 
Recombination of the conditional allele of EG by Pax3-cre was verified by PCR of exons 3-7 from 
cDNA of E13.5 kidney lysates of EGflox/flox; Podxl1flox/flox; Pax3-cre and EGflox/flox; Podxl1flox/flox mice. 
See Supplemental Materials and Methods for details. Mice were maintained on mixed genetic 
backgrounds and genotyped by PCR. Procedures were performed according to UTSW IACUC-
approved guidelines.  
 
Histology and immunofluorescence: 
For paraffin sections, embryonic day 14.5 (E14.5) and post-natal day 0 (P0) kidneys were fixed in 4% 
paraformaldehyde (PFA) in PBS overnight at 4°C, embedded in paraffin and sectioned at 5 µm. 
E10.5 pancreases were collected and embedded in paraffin as previously described [26, 27]. For 
nonparaffin sections, E14.5 and P0 kidneys were fixed for 2h in 4% PFA/PBS, and E10.5 pancreases 
were fixed in 4% PFA/PBS overnight 4°C. Sections were permeabilized with 0.3% Triton X-100/PBS 
(PBST) and blocked with 10% donkey sera/PBST.  Sections were incubated with primary antibodies 
overnight (4°C), and then with fluorophore-conjugated secondary antibodies and mounted with 
Prolong Gold (Invitrogen).  
 
Antibodies:  
Primary antibodies were diluted 1:100 unless stated otherwise: Endoglycan (R&D, AF3534, 1:200), 
Podocalyxin (R&D, MAB1556), Calbindin (Swant, CB-38a, 1:1000), NCAM (DSHB, 5B8; GeneTex 
H28-123), Rab11 (Invitrogen, 71-5300), Ezrin (Abcam, ab41672), CD34 (eBioscience, RAM34), Par-
6b (SCBT, sc-67392, 1:400), Par-3 (Millipore, 07-330), aPKC (SCBT, C-20, 1:300), NHERF1 (Abcam, 
ab3452), Phalloidin 647 (Invitrogen, 42008A, 1:200). Secondary antibodies were purchased from 
Jackson ImmunoResearch, PA, USA. 
 
Imaging and statistical analysis: 
Confocal imaging was performed on a Zeiss LSM510 META laser scanning confocal microscope. 
Immunofluorescence and light microscopy were performed with a Nikon TE300 inverted fluorescence 
microscope (AxioCam HRc camera and AxioVision 4.5 software). Images were minimally processed 
and resampled to 300 dpi using Adobe Photoshop. The 3-D reconstruction of a z-stack was 
performed with the LSM510 3-D module and ImageJ. 
 
Transmission electron microscopy: 
Dissected embryonic kidneys at E14.5 were fixed in 2.5% glutaraldehyde in 0.1 M Na+cacodolate. 
Kidneys were post-fixed in 1% buffered OsO4, en bloc stained in 2% uranyl acetate, dehydrated and 
embedded in EMbed-812 resin. Sections were cut on a Leica EM UC6 ultramicrotome and stained 
with 2% uranyl acetate and lead citrate. Images were acquired on a FEI Tecnai G2 Spirit. 
 
RESULTS 
 
Endoglycan localizes to intracellular vesicles in nephron progenitor cells 
A schematic of the early steps of nephron tubulogenesis is depicted as Fig 1A. The cap mesenchyme 
containing nephron progenitor cells compact to form a pretubular aggregate, which subsequently 
undergoes a MET to form a polarized epithelial sphere called the renal vesicle. The renal vesicle 
undergoes morphogenesis to form an intermediate structure called the extended renal vesicle, and 
then forms an s-shaped tubule called the s-shaped body. At the s-shaped body stage, the lumen is 
continuous with the lumen of the ureteric bud [4]. As the s-shaped body continues to elongate, 
endothelial and mesangial precursors invade the proximal “tail” of the s-shaped body. When viewed 
in cross-section, this appears to form a loop, and is aptly named the capillary loop stage.   
 
The Genitourinary Developmental Molecular Anatomy Project (GUDMAP) database showed 
Endoglycan is expressed in the developing kidney, particularly in the metanephric mesenchyme and 
renal vesicles [28]. In the cap mesenchyme, which contains the nephron epithelial progenitors, we 
found Endoglycan (EG) localized to numerous intracellular puncta that appeared vesicular in nature 
(Fig 1B). We also noted the presence of EG in the renal stroma (not shown). The distribution of EG-
containing puncta in the cap mesenchyme was not polarized with respect to the CM-UB interface. 
When progenitors compacted to form a pretubular aggregate (Fig1C), the puncta appeared to cluster 
and form higher-order structures. During lumen formation at the renal vesicle stage, these puncta 
relocalized to the apical cell surface (Fig 1D). When a renal vesicle elongates, its lumen extends 
toward the UB and forms small discrete lumens in the connecting region that eventually become 
continuous at the s-shaped body stage [4]. EG was present at the leading edge of an extending 
lumen  (Fig 1E, asterisks) and at the discrete de novo lumens (not shown), indicating it is an early 
luminal component in developing nephrons. EG was also observed in intracellular puncta of adjacent 
cells that had not yet polarized (Fig 1E, arrow). Interestingly, in widened portions of the maturing 
lumen, such as the extended renal vesicle and mid-s-shaped body tubule, EG often appeared to 
partially fill the lumen with large, circular structures (Fig 1E, arrowhead) suggestive of extracellular 
vesicles. In s-shaped body tubules, EG was localized to the apical/luminal surface, including the 
proximal portion containing podocyte precursors (Fig 1F, arrows). A low level of EG was also present 
in the capillary loop stage, but EG was not present in maturing tubules or glomeruli of neonatal 
kidneys or in adult kidneys (not shown).  
 
To determine if EG expression in developing epithelial tubules was specific to the kidney, we also 
examined its expression in the developing pancreas (Fig S1). The pancreas bud emerges from the 
endoderm ~E8.75 in mice, and undergoes rapid stratification. By E10.5, the stratified epithelium 
remodels to form rosettes that then open to form central microlumens. These microlumens then 
coalesce as the epithelium remodels into a single-layered epithelial tubular network, beginning 
around E12.5 [26]. Using immunofluorescence, we found that EG colocalizes with many, but not all, 
aPKC+ microlumens in the pancreas at E10.5. As microlumens form asynchronously in the pancreas 
and EG expression decreases as micolumens mature, it may explain why EG is not observed in all 
microlumens.  
 
Endoglycan expression precedes Podocalyxin expression during nephron development 
Because EG was expressed intracellularly in the cap mesenchyme and pretubular aggregates, we 
investigated if Podocalyxin was also expressed prior to lumen formation, as previously observed in 
MDCK cells [29]. Podocalyxin was not evident at these stages (not shown and Fig 1G). In renal 
vesicles, faint immunostaining of Podocalyxin was evident at the luminal surface (Fig H). Low levels 
of Podocalyxin were also present at the apical surface of s-shaped bodies, especially at the apical 
surface of podocyte precursors (Fig 1I, arrows). Podocalyxin is also produced by endothelia [30], and 
this is indicated in the images (arrowheads in Fig 1I-J) to serve as a reference for image intensity. 
Note that Podocalyxin was more abundant in the capillary endothelium compared with the s-shaped 
body lumen. At a later developmental stage, the capillary loop stage of glomerulogenesis, increased 
levels of Podocalyxin were observed at the apical surface of podocytes (Fig 1J, arrows, and [31]), 
exceeding levels in the endothelia (Fig 1J, arrowheads). Lastly, we found that CD34 was not present 
in developing renal epithelia, although it was abundantly produced by the endothelia (not shown). 
  
From these studies we concluded that EG is the only CD34 family member to be expressed in 
nephron progenitors prior to lumen formation, suggesting it may participate in nephron lumen 
formation akin to the role of Podocalyxin in MDCK cells. We also found that EG is produced by the 
epithelia only during early tubulogenesis, suggesting a role in lumen formation but not maintenance. 
Finally, we noted a temporal relationship between EG and Podocalyxin levels. EG levels were high at 
the onset of lumen formation, declining thereafter, while Podocalyxin levels increased as EG 
declined. In the maturing nephron, Podocalyxin levels were highest in podocytes. 
 
Endoglycan is present in Rab11-containing endosomes prior to lumen formation 
Electron microscopy studies conducted by Saxen and Wartiovaara in the 1960s showed subapical 
vesicles in pretubular aggregates [32]. Because EG was observed in small puncta prior to lumen 
formation, we examined whether EG colocalized with Rab11, a known marker of recycling 
endosomes [33]. Prior to lumen formation, EG colocalized highly with Rab11 vesicles (Fig 2A). The 
amount of colocalization decreased after lumen initiation in the renal vesicle stage, where EG was 
mostly apical (Fig 2B). These results suggest that EG is transported to the apical surface via vesicular 
transport, and specifically via Rab11-containing endosomes. Together the data suggest a model in 
which intracellular vesicles containing apical components move to a forming apical surface and 
coalesce to form a lumen.  
 
Lumens of developing nephrons contain extracellular vesicles 
The large EG-containing circular structures observed in the widened lumens of the extended renal 
vesicle and s-shaped body suggested the presence of extracellular vesicles (Fig 1D). The size of 
these structures, ~1 μm, was much larger than the intracellular EG-, Rab11-containing endosomes. 
This suggested that EG is not only a component of recycling endosomes, but may also be a 
component of extracellular vesicles that are being shed into the lumen. We examined other apical 
markers for a similar pattern of immunolocalization, and found that Ezrin, a known interactant of 
Podocalyxin, also localized to intraluminal structures (Fig 3A, B). Ezrin was not observed prior to 
lumen formation (not shown).  Surprisingly, EG and Ezrin only partially colocalized within the lumen. 
We observed the vesicular structures adjacent to the apical surface in some images (Fig 3B), 
suggesting they might be budding from the plasma membrane. Electron microscopy revealed 
similarly-sized structures that also are consistent with a budding process from the plasma membrane 
(Fig 3C) although further experiments are needed to test this hypothesis. To determine if other known 
components of exosomes also localized to the lumens, we examined nephron lumens for CD63, a 
tetraspanin present in a subset of exosomes. However, we did not observe CD63 in nephron epithelia 
(not shown). 
 
Endoglycan is not required for lumen formation in nephrons 
To investigate if Endoglycan is an apical membrane protein required for nephron lumen formation, we 
generated mice (Podxl2tm1a(EUCOMM)Wtsi ) globally lacking Endoglycan. Immunostaining of neonatal 
(P0) kidneys showed Endoglycan was absent (Fig 4A). Immunostaining with an apical marker such 
as aPKC revealed no delay of normal lumen formation in renal vesicles (Fig 4A). Three-dimensional 
reconstruction of confocal z-stacks of s-shaped bodies from mutant mice at P0 showed that nephron 
lumens were continuous and indistinguishable from controls (Fig 4B). Neonatal mice lacking EG had 
kidneys with normal histology, as assessed by H&E staining (Fig 4C). The mutant renal vesicles did 
not exhibit increased Podocalyxin (or CD34, not shown) at the luminal surface compared with controls 
(Fig 4D), so functional family member compensation did not account for normal-appearing lumens. 
We also examined mutant mice at 3 months of age (n = 3), and found the mice to be healthy with 
normal-appearing renal histology (not shown). The tubules had normal diameter and no interstitial 
fibrosis. As mentioned earlier, Endoglycan is not produced in adult renal tubules, but this result 
supports the absence of a developmental defect. Defects in lumen formation can lead to profound 
renal dysgenesis in post-natal kidneys, as we have shown previously [4]. Similar to our results in 
kidney, mice lacking EG appeared to have normal lumen formation and tubule structure in developing 
pancreases (not shown). 
 Because we had observed faint immunostaining of Podocalyxin at the lumen of renal vesicles 
(Fig 1G), we questioned if there might be functional redundancy between EG and Podocalyxin, and 
decided to remove both EG and Podocalyxin from developing nephrons. To do this, we generated 
mice with conditional deletion of both EG and Podocalyxin from nephron progenitors using Six2-cre to 
generate EGflox/flox; Podxl1flox/flox; Six2-cre mice [24]. The mutant mice died in the neonatal period, 
similar to mice null for Podocalyxin [20]. As podocalxyin is already known to have a critical role in 
podocyte function [20], we limited our analysis to early stages of nephrogenesis. These mice had no 
obvious defects in timely lumen formation or luminal continuity (not shown). We next generated mice 
with conditional deletion of EG and Podocalyxin using the Pax3-cre, a Cre line with more widespread 
recombination, but importantly, with earlier recombination within nephron progenitors [19]. These 
mutant mice had no delay in timely lumen formation (Fig 5A), despite confirmation that both EG (Fig 
5A) and Podocalyxin (Fig 5B) were absent from mutant nephrons by immunofluorescence. We 
confirmed that EG was absent from the cap mesenchyme (not shown). There was also no 
compensatory expression of CD34 in the developing nephrons at the s-shaped body lumens, 
including the apical surface of developing podocytes (Fig 5C). Mutant lumens were not dilated or 
convoluted (n = 3 mutants). In addition to normal lumen initiation, the lumens of mutants were 
continuous at the s-shaped body stage, similar to controls (Fig 5D). Together, these results suggest 
that lumen formation in developing epithelial tubules, both in the kidney and pancreas, does not 
require CD34 family members.  
 
CD34 family members recruit NHERF1, but not Ezrin, to the forming apical surface of 
podocytes 
Podocalyxin forms a ternary complex with NHERF1/2 and Ezrin, the latter tethering it to the actin 
cytoskeleton [7-10]. Ezrin was detected as early as the renal vesicle stage (not shown and Fig 3A). 
NHERF1, in contrast, was not present in appreciable amounts until the s-shaped body stage, where it 
was prominent in podocyte precursors at the apical surface (Fig 6A), similar to Podocalyxin 
localization. Mice lacking both EG and Podocalyxin (EGflox/flox; Podxl1flox/flox; Pax3-cre) showed a 
mislocalization of apically localized NHERF1 in developing podocytes (Fig 6A). Ezrin still localized to 
the apical surface of podocytes lacking both EG and Podocalyxin (Fig 6B), suggesting its localization 
is not dependent on these proteins. We also observed that NHERF1 localized to the apical surface of 
maturing tubules (Fig 6A, arrowheads) and this was not changed in the absence of Podocalyxin and 
EG in nephron tubules (not shown), suggesting that NHERF1 requires Podocalyxin/EG for 
recruitment to the apical surface specifically in podocytes. Mice lacking NHERF1, in contrast to mice 
lacking Podocalyxin, have not been reported to have developmental defects in podocyte structure 
and function [34], so the functional consequences of this are unknown. 
 
DISCUSSION 
 
Many of the cellular and molecular mechanisms that underlie lumen formation in the kidney are 
not well understood. In this study, we report the localization and function of a CD34 family member, 
Endoglycan, in nephron epithelial tubulogenesis. Examination of this protein has led to several novel 
observations that help elucidate general principles of nephron lumen formation. First, we demonstrate 
that Endoglycan localizes to Rab11+ intracellular vesicles prior to lumen formation, which relocalize to 
the luminal surface during lumen initiation. This finding suggests a model of lumen formation in which 
intracellular vesicles containing apical components traffic to and fuse with a forming apical surface. 
Our results are consistent with observations made in the 1960’s by Saxen and Wartiovaara, who 
reported the presence of subapical vesicles in pretubular aggregates. Furthermore, this model of 
lumen formation, dubbed “hollowing” has been previously described in MDCK cells [35], a known and 
well-studied renal epithelial cell line.  
We also demonstrate that Endoglycan and Ezrin are present within the lumen. We frequently 
observed their localization in round, luminal structures of ~1 μm. Because the size of these structures 
is much larger than the Endoglycan-, Rab11-positive intracellular vesicles, we hypothesize that they 
represent a distinct cellular process. Electron microscopy images of the apical surface of the s-
shaped body stage, which has a continuous lumen, show apical membrane blebs of ~1 μm diameter 
that appear to be budding from the apical plasma membrane.  Together, this suggests that 
developing tubules may release Endoglycan-containing vesicles/exosomes into the lumen. This 
interpretation is bolstered by previous studies that have shown Podocalyxin is a component of 
exosomes in urine and cultured cells [36-38]. However, future studies with live imaging will determine 
if apical membrane blebs are indeed released into the lumen as extracellular vesicles/exosomes 
during normal tubulogenesis. 
At this point, we can only speculate on the roles that intraluminal structures play in developing 
tubules. It was recently shown that exosomes increase HGF-mediated outward growth and cell 
migration in MDCK cells [39]. Perhaps the intraluminal structures observed are similarly required for 
intercellular communication to drive nephron tubulogenesis and/or extend the lumen to adjacent cells 
in vivo. They may also serve to regulate the size of the apical domain. Another possibility is that 
luminal structures provide a “filler” to expand the luminal space. Although this is not a known role of 
luminal structures or exosomes, the deposition (and removal) of a structured protein matrix in the 
lumen of developing Drosophila trachea affects both lumen diameter and tubule length [40, 41].  
In developing nephrons, while Endoglycan localizes to intracellular vesicles and the nascent 
luminal surface of developing tubules, it is absent from more differentiated lumens, even during 
embryogenesis. This initially suggested it might be required to initiate lumen formation or expansion, 
as Podocalyxin does in MDCK cells, mouse aorta, and spheroids derived from human pluripotent 
stem cells [10, 20, 42]. However, neonatal and adult mice lacking Endoglycan were healthy and fertile 
without obvious renal abnormalities. This was not due to functional compensation by other known 
CD34 family members, Podocalyxin or CD34. Indeed, mice with nephron epithelia lacking both 
Endoglycan and Podocalyxin also had normal morphology in developing tubules, although as 
expected, these doubly deficient mice had defects in podocytes.  One possibility is that, due to its 
paramount importance, multiple signaling pathways are functionally redundant to ensure the fidelity of 
apical-basal polarity. Alternatively, the CD34 family/NHERF/Ezrin axis, while not essential for lumen 
formation, may have other specific roles in renal epithelial function.  
Doyonnas et al. [20] has previously demonstrated that mice lacking Podocalyxin die in the 
neonatal period with anuria and defective glomerular development [20]. While we did not examine the 
podocyte phenotype in depth in the current work, we found that EGflox/flox; Podxl1flox/flox; Pax3-cre mice, 
which lack both proteins from developing podocytes in addition to nephron tubular epithelia, had 
reduced NHERF1 at the apical surface of podocytes. This was not a disruption of apical-basal polarity 
per se, as Par6 and NCAM were apical and basal respectively. We did not observe a similar 
decrease in total Ezrin at the apical surface of podocytes (or other tubules). Interestingly, NHERF1 is 
present at the apical surface in proximal tubules [43], which lack Podocalyxin. This suggests 
Podocalyxin regulates NHERF1 localization in a cell type-specific manner.  
In summary, we provide a morphological analysis of lumen formation in developing nephron 
tubules and identify Endoglycan as a novel pre-luminal marker in this process.  
 
Figure Legends 
 
Figure 1. Endoglycan and Podocalyxin localization during lumen formation 
(A) General schematic of lumen formation in developing nephrons. The cap mesenchyme (not 
shown) compacts to form a pretubular aggregate (PA). The PA becomes a polarized, epithelial 
sphere called the renal vesicle (RV) containing a central lumen (purple). The RV becomes an 
extended structure, then forms the s-shaped body (SB), whose lumen is continuous with the ureteric 
bud (UB) lumen (purple). As the SB elongates, endothelial (red) and mesangial (brown) precursors 
invade the SB cleft and the SB “tail” forms a primordial glomerulus known as the capillary loop stage. 
Podocyte precursors are indicated (blue). 
(B-F) Localization of Endoglycan (EG) in P0 kidney in CM (B), PA (C), and RV (D) stages. EG 
localizes largely to punctate structures in CM and PA, then relocalizes to the nascent nephron lumen. 
NCAM marks the plasma membrane in CM and PA and becomes restricted to the lateral surfaces in 
RVs. aPKC marks apical, luminal surfaces (B). In extended RVs (E), EG localizes to the lumen, 
including the leading portion (asterisks), and is in contiguous cells prior to lumen formation (arrow). 
EG also localizes to intraluminal structures in the widened lumen (arrowhead). Calbindin marks the 
adjacent UB. (F) EG is apical (and intraluminal) in the SB stage, including the apical surface of 
podocyte precursors (arrows). 
(G-J) Localization of Podocalyxin (Podxl1) in P0 kidney shows it is absent from CM (not shown) and 
PA (G), but is present at low levels in RV (H, arrow). Podxl1 also localizes to endothelia (H, 
arrowheads), where levels are higher. (I) Podxl1 levels increase at the SB stage, where it is 
apical/luminal (asterisks indicate mid-SB and arrows indicate proximal SB where podocyte precursors 
reside). (J) Further increase in Podxl1 is observed in early glomeruli at the apical surface of immature 
podocytes (arrows) and in endothelia (arrowheads). Results are representative of 3 experiments. 
Scale bars: 5 μm. 
 
Figure 2. Endoglycan is present in Rab11-vesicles prior to lumen formation 
Immunolocalization of Endoglycan (EG) and Rab11a is shown in the cap mesenchyme (CM) (A) and 
early RV stage (B). Arrows in A indicate colocalization of EG and Rab11a. NCAM delineates the 
plasma membrane in the CM. Results are representative of 2 experiments. Scale bars: 5 μm. 
 
Figure 3. Endoglycan and Ezrin are present in intraluminal vesicles 
(A,B) Immunolocalization of EG and Ezrin in the intraluminal space of P0 kidney. NCAM marks the 
lateral plasma membrane in developing nephrons. B shows a high magnification image of a lumen 
(arrowhead indicates an extracellular vesicle with EG and Ezrin; arrow indicates an extracellular 
vesicle with Ezrin alone). (C) Transmission EM images showing intraluminal protrusions that appear 
to be budding from the plasma membrane. Results are representative of 2 experiments. Scale bars: 5 
μm A,B; 2 μm c,c’ and 0.5 μm c’’.  
 
Figure 4. Endoglycan is not required for nephron lumen formation 
(A) Immunolocalization of EG and aPKC in P0 kidneys from control and mutant Podxl2tm1a/tm1a (EGtg/tg) 
mice shows EG is absent from the renal vesicle in the EGtg/tg kidney. aPKC, a marker of the luminal 
surface, shows the renal vesicle has a central lumen in control and EGtg/tg images. (B) A 3-D 
reconstruction of a confocal z-stack shows an s-shaped body with a continuous lumen from the EGtg/tg 
kidney. (C) Hematoxylin and eosin stain of P0 sections from a control and EGtg/tg kidney. (D) 
Immunolocalization of Podocalyxin (Podxl1) shows little/no Podocalyxin in control and EGtg/tg renal 
vesicles. Par6b marks the apical surface. Results are representative of 2 experiments. Scale bars: 5 
μm A,B,D; 100 μm C.  
 
Figure 5. Absence of Endoglycan and Podocalyxin from developing nephron tubules 
(A,B,C) Immunolocalization of Endoglycan (A), Podocalyxin (B), and CD34 (C) in control (EGflox/flox; 
Podxl1flox/flox) and mutant (EGflox/flox; Podxl1flox/flox; Pax3-cre) E14.5 kidneys. Panel A shows mutants 
have a central lumen in renal vesicles, as delineated by Par6b, but lack Endoglycan.  (B) Podocalyxin 
is present in developing podocytes (arrows) of controls but not mutants. Other Podocalyxin+ 
structures are endothelial cells. (C) CD34 is absent from s-shaped body lumens (arrowhead), 
including developing podocytes (arrows), in controls and mutants. CD34+ structures are endothelial 
cells. (D) Continuous lumens, delineated by Par6b, are present in control and mutant s-shaped 
bodies. The mutant image (right) shows a lumen that is continuous with the UB lumen. Results are 
representative of 3 experiments. Scale bars: 10 μm A-D. 
 
Figure 6. CD34 family members recruit NHERF1, but not Ezrin, to the apical surface of 
podocytes 
Immunolocalization of NHERF1 (A) and Ezrin (B) in control (EGflox/flox; Podxl1flox/flox) and mutant 
(EGflox/flox; Podxl1flox/flox; Pax3-cre) P0 kidneys. (A) NHERF1 is present at the apical surface of 
developing podocytes (arrows) of controls but not mutants. Arrowheads show the apical surface of 
maturing tubules. NCAM delineates the lateral plasma membrane of developing nephron tubules. (B) 
Ezrin localizes to the apical surface of developing podocytes (arrows) of controls and mutants. 
Results are representative of 2 experiments. Scale bars: 10 μm. 
 
Figure S1. Endoglycan localizes to microlumens in developing pancreas 
Immunolocalization of EG, aPKC, and E-cadherin (white) in a mouse E10.5 pancreas. aPKC marks 
the micolumens and E-cadherin marks the basolateral surfaces. Inset depicts colocalization of EG to 
an aPKC+ microlumen. Results are representative of 3 experiments. Scale bars: 10 μm. 
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